Issuer
Replek AD Skopje
Issuer's basic data
Address
Ul.Kozle 188
City
Skopje
State
Makedonija
Mail
info@replek.mk
Contact person +
Julijana Koleva Rusovska
Phone
+389 2 3081 343
Fax
/
Prospectus
Year 2023 2022 2021
Total Revenue from operation Activities 1,587,371 1,251,666 1,220,160
Operating profit 307,565 104,776 161,194
Net profit 280,628 81,937 134,793
Equity 2,298,036 1,533,835 1,560,517
Total liabilities 703,197 729,264 559,862
Total assets 3,001,233 2,263,099 2,120,379
Market capitalization 2,410,560 2,269,296 2,639,952
* data in 000 MKD
Methodology
Year 2023 2022 2021
Return on sales 19.38% 8.37% 13.21%
Net earnings per share (EPS) 10,826.71 3,161.15 5,200.34
Return on assets 9.35% 3.62% 6.36%
Return on equity 12.21% 5.34% 8.64%
Price to earnings 8.59 27.70 19.59
Book value per share 88,658.82 59,175.73 60,205.12
Price to Book Value 1.05 1.48 1.69
Dividend Per Share 2,000.00
Dividend yield 0.00% 2.28% 0.00%
Replek is a company whose main activity is the production of pharmaceutical products, cosmetic products and cannabis products. The production range of the company has high quality products, for the production of which the company has an EU GMP quality certificate. Within the framework of the market strategy, the company also focuses on trade, ie. import of drugs, nutritional supplements and medical devices, registration and marketing of drugs, logistics as well as development and support of sales strategies for different markets and partners. Currently, the company is represented in 20 countries around the world. By providing high quality services and products, the company has a significant place in the domestic pharmaceutical market. With the constant development of innovative products and services, the company promotes the well-being of all participants – users, employees and of course shareholders.

Managing Board
Dushan Pecovski - President and General manager
Gelevski Pance
Kosta Koteski
Marjan Velkovski
Supervisory Board 
Antonio Georgievski - President
Petar Andreevski
Tomislav Krstevski - acting member
Naum Janakiev 
Jana Juzina - independent member

  1. Non-trade transfers of listed companies' share

    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
  2. Block trade

    Block trade with shares of Replek AD Skopje
  3. Block trades

    Block trades with shares of Replek AD Skopje
  4. Share buy-backs and non-trade transfers of listed companies' shares

    We inform you about executed share buy-backs and non-trade transfers of listed companies' shares
  5. Block trades

    Block trades with shares of Replek AD Skopje
  6. Non-trade transfers of listed companies' share

    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
  7. Share buy-backs and non-trade transfers of listed companies' shares

    We inform you about executed share buy-backs and non-trade transfers of listed companies' shares
  8. Share buy-backs and non-trade transfers of listed companies' shares

    Share buy-backs and non-trade transfers of listed companies' shares
  9. Non-trade transfers of listed companies' share

    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
  10. Non-trade transfers of listed companies' share

    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed
Symbols
Price movement
Volume
Symbol data
Market segment:
Exchange Listing - Ordinary shares
ISIN:
MKREPL101013
Total shares
25,920
Last trade: 4/18/2024
Max Price:
109,400.00
Min Price:
109,400.00
Avg Price:
109,400.00
Volume:
1
Value:
109,400
Trades:
1
Last 52 weeks
Max Price:
112,789.00
Min Price:
75,000.00
Volume:
361
Value:
32,219,287
Trades:
145

* the average price is from the last trading day

**data doesn't inculde block trades

*** the ordinary shares and the priority shares own by the Pension and Disability Insurance Fund of the Republic of Macedonia – PDIF (if they are issued) are summed up. The priority shares own by the PDIF are converted in ordinary shares at the moment of sale.

Historical Data